Skip to main content

Table 1 Patient characteristics and treatments

From: Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases

Patient No. Age (years) Gender Pathology AV (cm) Initial stage* MRF involvement DM site Preoperative treatment
1 52 M Adeno MD 7.8 T4aN1M1a + Liver E-FOLFOX #9 + RT (25 Gy/5fx) + E-FOLFOX #3
2 39 F Adeno MD 7 T4aN0M1b + Peritoneum,
Lt. ovary
A-FOLFOX #7 + RT (25 Gy/5fx) + A-FOLFOX #2
3 56 M Adeno MD 4 T3N2aM1a + Liver FOLFOX #4 + RT (25 Gy/5fx) + FOLFOX #4
4 45 F Adeno WD 8 T3N2aM1a Threatened Liver,
both ovaries
FOLFOX #4 + RT (25 Gy/5fx)
5 63 M Adeno MD 1 T4N1aM1a + Liver FOLFOX #4 + RT (25 Gy/5fx) + FOLFOX #4
6 60 M Adeno MD 7 T3N2bM1a + Liver FOLFOX #4 + RT (25 Gy/5fx) + FOLFOX #5
  1. Abbreviations: AV, anal verge; MRF, mesorectal fascia; adeno, adenocarcinoma; MD, moderately differentiated; Lt., left; FOLFOX, 5-fluorouracil/leucovorin/oxaliplatin; E, erbitux; RT, radiation therapy; A, avastin.
  2. *AJCC 7th edition.